The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair

Tue, 10th Mar 2020 09:38

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

BOFA RAISES EASYJET TO 'BUY' ('NEUTRAL') - PRICE TARGET 1330 PENCE

----------

BERNSTEIN RAISES EASYJET TO 'OUTPERFORM' ('MARKET-PERFORM') - PRICE TARGET 1300 (1450) PENCE

----------

BERNSTEIN CUTS IAG PENCE PRICE TARGET TO 490 (700) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS VODAFONE PRICE TARGET TO 190 (210) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS BT GROUP PRICE TARGET TO 210 (240) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE CUTS BRITISH AMERICAN TOBACCO PRICE TARGET TO 4070 (4200) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS IMPERIAL BRANDS PRICE TARGET TO 1700 (2100) PENCE - 'NEUTRAL'

----------

PANMURE RAISES HARGREAVES LANSDOWN TO 'BUY'

----------

ODDO BHF CUTS ANGLO AMERICAN PRICE TARGET TO 2400 (2500) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS BARCLAYS PRICE TARGET TO 215 (240) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS LLOYDS PRICE TARGET TO 47 (54) PENCE - 'SELL'

----------

GOLDMAN CUTS HSBC PRICE TARGET TO 750 (785) PENCE - 'CONVICTION BUY LIST'

----------

GOLDMAN CUTS ROYAL BANK OF SCOTLAND PRICE TARGET TO 280 (335) PENCE - 'BUY'

----------

CITIGROUP RAISES HIKMA PHARMA TO 'BUY' ('NEUTRAL') - TARGET 2150 (1980) PENCE

----------

BERENBERG CUTS MEGGITT TO 'HOLD' ('BUY') - TARGET 490 (695) PENCE

----------

EXANE BNP CUTS ROYAL DUTCH SHELL PRICE TARGET TO 1600 (2300) PENCE - 'NEUTRAL'

----------

EXANE BNP CUTS BP PRICE TARGET TO 430 (600) PENCE - 'OUTPERFORM'

----------

FTSE 250

----------

STIFEL CUTS PREMIER OIL TO 'HOLD'

----------

JPMORGAN RAISES ULTRA ELECTRONICS TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 2450 (2400) PENCE

----------

GOLDMAN CUTS VIRGIN MONEY PRICE TARGET TO 180 (184) PENCE - 'NEUTRAL'

----------

BERENBERG CUTS ASCENTIAL TO 'HOLD' ('BUY') - TARGET 300 (470) PENCE

----------

BARCLAYS CUTS NETWORK INTERNATIONAL PRICE TARGET TO 520 (640) PENCE - 'OVERWEIGHT'

----------

BARCLAYS INITIATES SOFTCAT WITH 'OVERWEIGHT' - TARGET 1220 PENCE

----------

RBC CUTS WH SMITH PRICE TARGET TO 2000 (2750) PENCE - 'OUTPERFORM'

----------

RBC RAISES MONEYSUPERMARKET.COM TO 'SECTOR PERFORM' ('UNDERPERFORM') TARGET 320 (300) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

STIFEL CUTS GENEL TO 'HOLD'

----------

JPMORGAN RAISES ABCAM PRICE TARGET TO 1188 (1134) PENCE - 'NEUTRAL'

----------

LIBERUM CUTS ABCAM PRICE TARGET TO 1290 (1370) PENCE - 'HOLD'

----------

LIBERUM CUTS SPIRE HEALTHCARE PRICE TARGET TO 125 (133) PENCE - 'HOLD'

----------

BERENBERG RAISES TEAM17 PRICE TARGET TO 550 (500) PENCE - 'BUY'

----------

BERENBERG CUTS MIDWICH GROUP PRICE TARGET TO 620 (670) PENCE - 'BUY'

----------

GOLDMAN RAISES BANK OF IRELAND TO 'NEUTRAL' ('SELL') - TARGET 3,60 (4,30) EUR

----------

GOLDMAN CUTS ALLIED IRISH BANKS PRICE TARGET TO 3,40 (3,90) EUR - 'BUY'

----------

GOLDMAN CUTS ARROW GLOBAL PRICE TARGET TO 240 (250) PENCE - 'NEUTRAL'

----------

BERNSTEIN RAISES RYANAIR TO 'OUTPERFORM' (MARKET-PERFORM) - PRICE TARGET 13.30 (15) EUR

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.